Concord Medical Services Holdings Limited (CCM)

CCM Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	365.76	383.96	537.4	472.09	485.63	223.01
Revenue Growth (YoY)	-22.46%	-28.55%	13.84%	-2.79%	117.76%	12.43%
Cost of Revenue	407.61	463.12	614.01	624.49	542.53	209.93
Gross Profit	-41.85	-79.16	-76.61	-152.41	-56.9	13.08
Selling, General & Admin	437.22	453	386.38	372.64	401.42	320.58
Operating Expenses	437.22	453	386.38	372.64	401.42	320.58
Operating Income	-479.07	-532.16	-462.99	-525.05	-458.32	-307.5
Interest Expense	-212.19	-193.2	-165.67	-120.36	-73.79	-81.36
Interest & Investment Income	12.57	13.98	10.83	10.02	5.89	8.44
Earnings From Equity Investments	14.1	12.7	20.79	17.65	18.16	6.02
Currency Exchange Gain (Loss)	10.9	-17.47	10.15	54.98	-19.93	-58.69
Other Non Operating Income (Expenses)	97.4	-9.1	-5.57	-11.35	-1.26	6.31
EBT Excluding Unusual Items	-556.3	-725.25	-592.45	-574.1	-529.24	-426.77
Gain (Loss) on Sale of Investments	38.01	7.17	37.5	-	-	7.84
Gain (Loss) on Sale of Assets	0.5	48.5	-0.64	-61.55	-	-14.22
Asset Writedown	-	-	-	-	-	-8.5
Other Unusual Items	-	-	-	-204.25	-	-
Pretax Income	-517.79	-669.58	-555.59	-839.9	-529.24	-441.65
Income Tax Expense	10.95	-17.51	-24.57	-70.91	-6.57	-37.62
Earnings From Continuing Operations	-528.74	-652.08	-531.02	-768.99	-522.67	-404.03
Net Income to Company	-528.74	-652.08	-531.02	-768.99	-522.67	-404.03
Minority Interest in Earnings	365.62	343.83	233.36	279.33	251.25	94.04
Net Income	-163.12	-308.24	-297.66	-489.66	-271.43	-309.99
Preferred Dividends & Other Adjustments	-	-	-	-	549.19	359.92
Net Income to Common	-163.12	-308.24	-297.66	-489.66	-820.62	-669.91
Shares Outstanding (Basic)	4	4	4	4	4	4
Shares Outstanding (Diluted)	4	4	4	4	4	4
Shares Change (YoY)	-	-	-	-	-	0.63%
EPS (Basic)	-37.34	-70.56	-68.14	-112.09	-187.85	-153.35
EPS (Diluted)	-37.56	-70.56	-68.14	-112.09	-187.85	-153.35
Free Cash Flow	-	-798.42	-392.17	-600.47	-1,120	-734.47
Free Cash Flow Per Share	-	-182.77	-89.77	-137.46	-256.36	-168.13
Gross Margin	-11.44%	-20.62%	-14.26%	-32.28%	-11.72%	5.87%
Operating Margin	-130.98%	-138.60%	-86.15%	-111.22%	-94.38%	-137.89%
Profit Margin	-44.60%	-80.28%	-55.39%	-103.72%	-168.98%	-300.39%
Free Cash Flow Margin	-	-207.95%	-72.98%	-127.19%	-230.60%	-329.34%
EBITDA	-356.79	-411.03	-344.16	-401.86	-363.86	-236.72
EBITDA Margin	-97.55%	-107.05%	-64.04%	-85.13%	-74.92%	-106.14%
D&A For EBITDA	122.28	121.13	118.83	123.19	94.46	70.79
EBIT	-479.07	-532.16	-462.99	-525.05	-458.32	-307.5
EBIT Margin	-130.98%	-138.60%	-86.15%	-111.22%	-94.38%	-137.89%
Revenue as Reported	365.76	383.96	537.4	472.09	485.63	223.01

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q